View in EDS HTML Full Text PDF Full Text

Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult leukemia group.

Saved in:
Bibliographic Details
Title: Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult leukemia group.
Authors: Zielonka, Klaudia1 (AUTHOR), Izdebski, Błażej2 (AUTHOR), Drozd-Sokołowska, Joanna1 (AUTHOR), Pruszczyk-Matusiak, Katarzyna2 (AUTHOR), Puła, Bartosz3,4 (AUTHOR), Wiśniewski, Kamil5 (AUTHOR), Sawicki, Waldemar6 (AUTHOR), Kalicińska, Elżbieta7 (AUTHOR), Jabłonowska-Babij, Paula7 (AUTHOR), Butrym, Aleksandra8,9 (AUTHOR), Buczek, Tomasz9,10 (AUTHOR), Subocz, Edyta11 (AUTHOR), Hałka, Janusz11,12 (AUTHOR), Witkowska, Magdalena4 (AUTHOR), Wilk, Mateusz13 (AUTHOR), Hryniewiecka, Maria14 (AUTHOR), Gruenpeter, Karolina15 (AUTHOR), Cichocka, Edyta16 (AUTHOR), Halicki, Piotr17 (AUTHOR), Wdowiak, Kamil18 (AUTHOR)
Source: Leukemia & Lymphoma. Dec2025, Vol. 66 Issue 12, p2191-2199. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2025.2535693